02
BEFORE / AFTER

What changed from existing technology?

Previous limitation

This study tested if adding health education to lung rehabilitation helps people recover better after being sick with COVID-19.

→
This research

This study is the first to examine how structured patient education can improve outcomes when added to standard pulmonary rehabilitation for acute COVID-19 patients.

03
COMMERCIALIZATION WATCH

Commercialization signals visible at publication

Publication-time signal score56/100

This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.

Verified evidence · 2
사람 대상·임상 근거

The added value of patient education in pulmonary rehabilitation of acute COVID-19 cases: a randomized controlled study.

Title ↗
인허가 근거

of structured patient education on clinical outcomes remains underexplored. This study aims to evaluate the impact of a standard versus education-enhanc

Abstract ↗
Evidence not yet confirmed
  • 시제품·장치 구현 근거 미확인
  • 제조·규모 확장 근거 미확인
Current tracking point2026-09-02 · Paper published

Later patent, company, clinical, and production events are added separately only after verification.

Patent check: Not checked yet
04 · REALITY CHECK

Current technology stage: Near commercialization

See what changed before reading the full paper.

Current stageNear commercialization
Basic researchExperimental validationPrototypeField validationNear commercialization
05
REMAINING CHALLENGES

What still needs to be solved?

Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.

06
INDUSTRY OPPORTUNITY

What could change if this succeeds?

07 · ONE MORE POSSIBILITYOne possibility beyond the paper

The findings suggest that adding structured education to pulmonary rehabilitation may improve recovery outcomes for acute COVID-19 patients, but further research is needed to confirm these results.

09 · EVIDENCE & SOURCES

Evidence and sources